Literature DB >> 1312615

Inhibition of poliovirus RNA synthesis by brefeldin A.

L A Maynell1, K Kirkegaard, M W Klymkowsky.   

Abstract

Brefeldin A (BFA), a fungal metabolite that blocks transport of newly synthesized proteins from the endoplasmic reticulum, was found to inhibit poliovirus replication 10(5)- to 10(6)-fold. BFA does not inhibit entry of poliovirus into the cell or translation of viral RNA. Poliovirus RNA synthesis, however, is completely inhibited by BFA. A specific class of membranous vesicles, with which the poliovirus replication complex is physically associated, is known to proliferate in poliovirus-infected cells. BFA may inhibit poliovirus replication by preventing the formation of these vesicles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312615      PMCID: PMC288987     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Regulation of translation by poliovirus.

Authors:  N Sonenberg
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

2.  Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.

Authors:  A M Bonneau; N Sonenberg
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

3.  Characterization of poliovirus-specific structures associated with cytoplasmic membranes.

Authors:  L A Caliguiri; I Tamm
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

4.  Virus replication, cytopathology, and lysosomal enzyme response of mitotic and interphase Hep-2 cells infected with poliovirus.

Authors:  K Bienz; D Egger; D A Wolff
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

5.  Antiviral activity of brefeldin A and verrucarin A.

Authors:  G Tamura; K Ando; S Suzuki; A Takatsuki; K Arima
Journal:  J Antibiot (Tokyo)       Date:  1968-02       Impact factor: 2.649

6.  Kinetics and location of poliovirus macromolecular synthesis in correlation to virus-induced cytopathology.

Authors:  K Bienz; D Egger; Y Rasser; W Bossart
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

7.  Poliovirus mutant that does not selectively inhibit host cell protein synthesis.

Authors:  H D Bernstein; N Sonenberg; D Baltimore
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

8.  Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited.

Authors:  P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Poliovirus metabolism and the cytoskeletal framework: detergent extraction and resinless section electron microscopy.

Authors:  H G Weed; G Krochmalnic; S Penman
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

10.  Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER.

Authors:  J Lippincott-Schwartz; L C Yuan; J S Bonifacino; R D Klausner
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

View more
  117 in total

1.  Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes.

Authors:  C A Blank; D A Anderson; M Beard; S M Lemon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Complex dynamic development of poliovirus membranous replication complexes.

Authors:  George A Belov; Vinod Nair; Bryan T Hansen; Forrest H Hoyt; Elizabeth R Fischer; Ellie Ehrenfeld
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

Review 4.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

Review 5.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

6.  Grapevine fanleaf virus replication occurs on endoplasmic reticulum-derived membranes.

Authors:  C Ritzenthaler; C Laporte; F Gaire; P Dunoyer; C Schmitt; S Duval; A Piéquet; A M Loudes; O Rohfritsch; C Stussi-Garaud; P Pfeiffer
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Isolation of enzymatically active replication complexes from feline calicivirus-infected cells.

Authors:  Kim Y Green; Aaron Mory; Mark H Fogg; Andrea Weisberg; Gaël Belliot; Mariam Wagner; Tanaji Mitra; Ellie Ehrenfeld; Craig E Cameron; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Picornavirus genome replication. Identification of the surface of the poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg uridylylation and construction of a structural model for the PV 3C2-3Dpol complex.

Authors:  Miaoqing Shen; Zachary J Reitman; Yan Zhao; Ibrahim Moustafa; Qixin Wang; Jamie J Arnold; Harsh B Pathak; Craig E Cameron
Journal:  J Biol Chem       Date:  2007-11-09       Impact factor: 5.157

9.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively.

Authors:  J M Mackenzie; E G Westaway
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.